| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/27/2002 | CA2714357A1 Mutations in neuronal gene sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 06/27/2002 | CA2436699A1 Piperidine derivatives as subtype selective n-methyl-d-aspartate antagonists |
| 06/27/2002 | CA2433027A1 Nucleic acid-associated proteins |
| 06/27/2002 | CA2433018A1 Thiazolyl inhibitors of tec family tyrosine kinases |
| 06/27/2002 | CA2432908A1 Diamines as modulators of chemokine receptor activity |
| 06/27/2002 | CA2432762A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 06/27/2002 | CA2432760A1 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof |
| 06/27/2002 | CA2432638A1 Therapeutic combination of amlodipine and benazepril |
| 06/27/2002 | CA2432315A1 Methods for the production of multimeric proteins, and related compositions |
| 06/27/2002 | CA2432310A1 Electrically responsive promoter system |
| 06/27/2002 | CA2432282A1 Therapeutic combination of amlodipine and benazepril/benazeprilat |
| 06/27/2002 | CA2431995A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
| 06/27/2002 | CA2431985A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
| 06/27/2002 | CA2431891A1 Mutations in neuronal gene sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 06/27/2002 | CA2431588A1 Benzylamine derivatives and their use as thrombin inhibitors |
| 06/27/2002 | CA2431147A1 Pharmaceutical formulation comprising thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2) |
| 06/27/2002 | CA2431139A1 Oxidoreductases |
| 06/27/2002 | CA2431077A1 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives |
| 06/27/2002 | CA2431074A1 Pharmaceutical formulation comprising thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (1) |
| 06/27/2002 | CA2431023A1 Substituted benzoindoles as spla2 inhibitors |
| 06/26/2002 | EP1217080A2 Methods, compositions and kits relating to cardiovascular disease |
| 06/26/2002 | EP1217002A1 2-(4-pyridinyl)-benzofurans as metalloprotease inhibitors |
| 06/26/2002 | EP1217001A1 Quinuclidine compounds and drugs containing the same as the active ingredient |
| 06/26/2002 | EP1217000A1 Inhibitors of factor Xa and factor VIIa |
| 06/26/2002 | EP1216707A1 New therapeutic uses of a SMR-1-peptide |
| 06/26/2002 | EP1216702A2 Aminotetralin derivative for the therapy of cardiovascular diseases |
| 06/26/2002 | EP1216257A1 Compounds for the treatment of ischemia |
| 06/26/2002 | EP1216248A2 Triazolopyrimidine derivatives |
| 06/26/2002 | EP1216246A1 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
| 06/26/2002 | EP1216245A1 Pharmaceutically active sulfonyl hydrazide derivatives |
| 06/26/2002 | EP1216238A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 06/26/2002 | EP1216233A1 Quinazolinones |
| 06/26/2002 | EP1216230A2 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 06/26/2002 | EP1216228A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa |
| 06/26/2002 | EP1216225A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 06/26/2002 | EP1216223A1 Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 06/26/2002 | EP1216222A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 06/26/2002 | EP1216040A1 Agents for reducing cholesterol-uptake and lipid-uptake |
| 06/26/2002 | EP1216038A2 Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
| 06/26/2002 | EP1216037A2 Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents |
| 06/26/2002 | EP1216026A1 Compositions of tocol-soluble therapeutics |
| 06/26/2002 | EP1216024A1 Formulation for menopausal women |
| 06/26/2002 | EP1143998A4 Treatment of hypertension |
| 06/26/2002 | EP1051155B1 Nasal solutions |
| 06/26/2002 | EP1049689B1 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists |
| 06/26/2002 | EP0896530B1 Dosage forms and uses |
| 06/26/2002 | EP0894084B1 Cinnamic acid derivatives and their use as integrin antagonists |
| 06/26/2002 | EP0820441B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS |
| 06/26/2002 | CN1355852A T cell receptor Vbeta-Dbeta-Jbeta sequence and methods for its detection |
| 06/26/2002 | CN1355850A Hyaluronidase from hirudinaria manillensis, isolation, purification and recombinant method of production |
| 06/26/2002 | CN1355843A Vascular adhesion molecules and modulation of their function |
| 06/26/2002 | CN1355811A Integrain receptor antagaonists |
| 06/26/2002 | CN1355810A Prodrugs of thrombin inhibitors |
| 06/26/2002 | CN1355805A Thienopyrimidines compound |
| 06/26/2002 | CN1355801A Thiazolidinedione derivative and its use as antidiabetic |
| 06/26/2002 | CN1355799A 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 06/26/2002 | CN1355788A 前列腺素e1衍生物 E1 prostaglandin derivative |
| 06/26/2002 | CN1355782A Benzene derivatives, preparation method and pharmaceutical compositions containing same |
| 06/26/2002 | CN1355707A Use of interleukin-11 to treat hemorrhagic shock |
| 06/26/2002 | CN1355702A Use of arylalkanoylpyridazines |
| 06/26/2002 | CN1355697A IL-8 receptor antagonists |
| 06/26/2002 | CN1355693A Controlled release and taste masking oral pharmaceutical compositions |
| 06/26/2002 | CN1355672A Method of increasing content of flavonoids and phenolic substances in plants |
| 06/26/2002 | CN1355255A Chitoser ester and its preparing process and application |
| 06/26/2002 | CN1355172A Process for extracting oleanolic acid-3-O-beta-D pyrane glucuronide from general aralia chinensis saponin and its usage |
| 06/26/2002 | CN1355171A Extracting process and usage of general aralic chinensis saponin |
| 06/26/2002 | CN1355032A Medical wine 'Luomaitong' |
| 06/26/2002 | CN1086704C Compound having antihypertensive, cardioprotective, anti-ischemic and ant ilipolytic functions |
| 06/26/2002 | CN1086700C Benzothiophene compounds, intermediates, composition, and methods |
| 06/26/2002 | CN1086698C Oxadizoles, processes for their preparation and their use as medicaments |
| 06/26/2002 | CN1086586C Medicine for treating cardiac and cerebral vascular diseases and its preparation method |
| 06/25/2002 | US6410802 Etherification in presence of base |
| 06/25/2002 | US6410790 Analgesics |
| 06/25/2002 | US6410787 Process to prepare 2-aminoindan derivatives |
| 06/25/2002 | US6410743 (1s,2s)-2-(2-(n-((3-benzoimidazol-2-yl)propyl)-n-methylamino)ethyl)-6 -fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl cyclopropanecarboxylate, for example; treating vascular disease such as gangrene, retinopathy, nephropathy |
| 06/25/2002 | US6410740 Heterocyclylmethyl-substituted pyrazol derivatives |
| 06/25/2002 | US6410739 Indole derivatives as 5-HT1 agonists |
| 06/25/2002 | US6410684 Serine protease inhibitors |
| 06/25/2002 | US6410601 Histochrome and its therapeutic use in acute myocardial infarction and ischemic heart disease |
| 06/25/2002 | US6410590 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
| 06/25/2002 | US6410589 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
| 06/25/2002 | US6410573 Cardiovascular diseases; potassium channel modulator |
| 06/25/2002 | US6410565 α1-adrenergic receptor antagonists |
| 06/25/2002 | US6410553 Benzosulfones and related compositions and methods |
| 06/25/2002 | US6410552 Benzoether and related compositions and methods |
| 06/25/2002 | US6410551 Bronchodilator |
| 06/25/2002 | US6410550 Aryl fused azapolycyclic compounds |
| 06/25/2002 | US6410542 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
| 06/25/2002 | US6410540 Inhibitors of p38-αkinase |
| 06/25/2002 | US6410535 Prophylactic or therapeutic agents for diseases having vascular dysfunction associated with insulin resistance |
| 06/25/2002 | US6410534 Anticancer agents |
| 06/25/2002 | US6410532 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 06/25/2002 | US6410530 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 06/25/2002 | US6410526 Bone disorders; restenosis; vision disorders; anticholesterol agents; anticancer, antitumor agents |
| 06/25/2002 | US6410524 Concurrent administering |
| 06/25/2002 | US6410322 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 06/25/2002 | US6410289 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 06/25/2002 | US6410054 Immediate release eplerenone compositions |
| 06/25/2002 | US6410020 Monoclonal antibody reactive to human CETP and assay method for human CETP |
| 06/25/2002 | US6410011 Treatment of restenosis by gene therapy, comprising the administration of a recombinant adenovirus containing a suicide gene |